polycystic ovarian syndrome
Conditions
Interventions
treatment group:The treatment group was treated with multi-sac I formula (cuscuta 15g, raspberry 12g, Morinda 10g, Euplia 10g, cooked ground 10g, Tuckaia 10g, cassia 3g, etc.). Cuscuta tonifying kidne
The combination of Shaozuo laurel branch and Tuckahoe Tongyang and Qi, water and dampness
Fritillaria thunbergii dissipates phlegm and disperses tangles, Zeilan, Chuanxiongxiong, peach kernel dissipates water and blood, removes blood stasis and produces new, replenishes without stagnation.
control group:The control group was treated with placebo, and the drugs in the treatment group and the control group were packaged with the same appearance, smell and color.
Sponsors
The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with PCOS were diagnosed according to the 2023 International Evidence-Based Guidelines; (2) In line with PCOS kidney-yang deficiency phlegm-dampness-blood stasis type syndrome differentiation criteria; ? Age: 18 ~ 40 years old, no fertility requirements; ? Willing to treat according to the treatment plan prescribed in this subject.
Exclusion criteria
Exclusion criteria: ? Hyperprolactinemia: Two serum prolactin levels = 25ng/ml, at least one week apart. ? Diminished ovarian reserve, FSH > 10 IU/L. ? Abnormal thyroid function, TSH 5.5 mIU/mL. ? Hypothalamic-pituitary amenorrhea. ? Suspected Cushing's syndrome patients. ? Patients suspected of secreting androgens due to adrenal or ovarian tumors. ? Specific family history of hirsutism. ? Poorly controlled type II diabetes patients. ? Pregnant or lactating women. ? Poorly controlled hypertension patients, with systolic blood pressure = 160 mmHg or diastolic blood pressure = 100 mmHg. Recent use of hormonal or other medications that may affect the results within the past 3 months. Presence of severe or acute conditions affecting the heart, liver, kidneys, blood, etc. Unwillingness to sign the informed consent form for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;WHR;Ferriman-gallwey hirsutism rating scale;Acne Pillsbury Rating Scale;Ludwig visual score evaluation criteria for androgen alopecia;menstruation;OGTT;gonadal hormone concentrations;Ovarian size and number of sinus follicles;PCOSQ;HADS;FSFI;Androgen level;glycosylated hemoglobin;thyrotropic hormone;Blood lipid; | — |
Countries
China
Contacts
Public ContactRuining Liang
The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Outcome results
None listed